Stock Research

Stock Quotes & Research Tools

Abbott Laboratories ABT:NYSE
Last PriceToday's ChangeToday's Volume
$102.03+1.96 (1.96%)11,963,581Above Average
As of 7:00pm ET, 07/19/2024
Company Performance
Details
Today's Open$100.61
Previous Close$100.07
Day's Range$100.08 - $102.40
52 Week range$89.67 - $121.64
Beta0.72
Avg. Volume (10 Day)7,782,171
Put/Call Ratio (1 Day)0.6
Put/Call Ratio (30 Day)0.6
Dividends
Quarterly Div. (Ann. Yield)$0.55 (2.16%)
Next Ex-DateJul 15, 2024
Next Pay DateAug 15, 2024
Shares
Market Capitalization (Large Cap)$177.5B
Shares Outstanding1.74B
Shares Held By Institutions74%
Headlines for Jul 20, 2024
There are no headlines for Jul 20, 2024
Additional Company News Providers
Company Headlines
  • Intuitive Surgical results beat on growing demand for surgical robots
  • UPDATE 3-Abbott raises profit forecast on strong medical device sales
  • CORRECTED-UPDATE 3-J&J beats Wall St estimates on strong drug sales ahead of Stelara competition
Press Releases
  • Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
  • Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
  • Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Edgar Filings
  • Form 8-K ABBOTT LABORATORIES For: Jul 18
  • Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Morrone Louis H.
  • Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Stratton John G
Research Provider Offering
Schwab's Variety of Detailed Stock Reports Help Investors Make Better Decisions

View the rationale behind our Schwab Equity Rating with details on what factors and components contribute to the overall rating.

Schwab Equity Rating Scale
 
 

Qualitative analysis on Morningstar’s global equity coverage. Analyst commentary, star ratings and economic moat evaluations.

Morningstar’s Rating Scale
 
 

This report contains the Argus rating and qualitative assessment of a stock's investment potential.

Argus 12 Month Rating Scale
 
Argus 5 Year Rating Scale
 
 

CFRA's Stock Reports contain equity analysis covering 5,000 publicly traded companies. The reports provide CFRA's ranking and qualitative opinion, financial statistics, and up to 10 years of summary balance sheet and income statement data.

CFRA's Opinion Scale
 
S&P Global's Earnings & Dividends Rank Scale
 
 

Detailed financials and consensus ratings from Refinitiv.

Refinitiv Stock Reports Plus
 
 

Manage market risk with quantitative technical analysis models from Market Edge.

Market Edge Second Opinion™ Weekly Rating Scale
 
Market Edge Second Opinion Score™ Scale
 
New to Schwab?
  or call 800-435-4000
Already a Schwab Client?
  to view our full client offering

Quotes are delayed by at least 15 minutes. Before trading, please check a real-time quote for current information.

Important Disclosures

Schwab Equity Ratings and other materials are for informational purposes only and is not an offer to sell or the solicitation of an offer to buy. Schwab Equity Ratings and the general buy/sell/hold guidance are not personal recommendations for any particular investor or client and do not take into account the financial, investment or other objectives or needs of, and may not be suitable for any particular investor or client. Before buying, investors and clients should consider whether the investment is suitable. Investors and clients should consider Schwab Equity Ratings as only a single factor in making their investment decision while taking into account the current market environment.

Schwab Equity Ratings utilize third-party data in the forming of a rating. Data is obtained from what are considered reliable sources; however, its accuracy, completeness or reliability cannot be guaranteed. Schwab Equity Ratings are generally updated weekly, so you should review and consider any recent market or company news before taking any action. Stocks may go down as well as up and investors (including clients) may lose money, including their original investment. Past performance is no indication of future results and returns are not guaranteed. For individualized advice, please contact Schwab at 1 (877) 284-9817. Note: An asterisk (*) next to a Schwab Equity Rating means that a potentially significant even has been announced for an A or B rated stock, Although Schwab generally does not monitor C, D, and F rated stocks for current news, from time to time, asterisks may appear on a particular stock due to certain circumstances (e.g. the downgrade of a stock from a B to C rating).

The news sources used on Schwab.com come from independent third parties. Schwab is not affiliated with any of the news content providers. Schwab is not responsible for the content, and does not write or control which particular article appears on its website. The securities markets (1) reserve all rights to the market data that they make available; (2) do not guarantee that data; and (3) shall not be liable for any loss due either to their negligence or to any cause beyond their reasonable control.

(0811-4793, 1214-7049)